このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Granules India 過去の業績
過去 基準チェック /26
Granules Indiaは、平均年間7.2%の収益成長を遂げていますが、 Pharmaceuticals業界の収益は、年間 成長しています。収益は、平均年間17% 14.7%収益成長率で 成長しています。 Granules Indiaの自己資本利益率は12.6%であり、純利益率は9%です。
主要情報
7.2%
収益成長率
8.2%
EPS成長率
| Pharmaceuticals 業界の成長 | 17.5% |
| 収益成長率 | 14.7% |
| 株主資本利益率 | 12.6% |
| ネット・マージン | 9.0% |
| 次回の業績アップデート | 30 Jul 2024 |
最近の業績更新
Recent updates
Granules India's (NSE:GRANULES) Dividend Will Be ₹1.50
Jun 19
Investors Holding Back On Granules India Limited (NSE:GRANULES)
Apr 08Granules India Limited Just Missed Revenue By 6.4%: Here's What Analysts Think Will Happen Next
Jan 26Many Still Looking Away From Granules India Limited (NSE:GRANULES)
Dec 28Granules India (NSE:GRANULES) Has A Pretty Healthy Balance Sheet
Nov 13A Look At The Fair Value Of Granules India Limited (NSE:GRANULES)
Oct 24Does Granules India (NSE:GRANULES) Have A Healthy Balance Sheet?
May 19Should You Be Adding Granules India (NSE:GRANULES) To Your Watchlist Today?
Mar 29Granules India (NSE:GRANULES) Has A Pretty Healthy Balance Sheet
Jan 19Does Granules India (NSE:GRANULES) Have A Healthy Balance Sheet?
Oct 01Estimating The Intrinsic Value Of Granules India Limited (NSE:GRANULES)
Aug 18Granules India (NSE:GRANULES) Is Due To Pay A Dividend Of ₹0.75
Jul 14Is Granules India (NSE:GRANULES) A Risky Investment?
Jun 28Granules India (NSE:GRANULES) Will Pay A Dividend Of ₹0.75
Jun 09Estimating The Fair Value Of Granules India Limited (NSE:GRANULES)
May 06Granules India (NSE:GRANULES) Is Due To Pay A Dividend Of ₹0.25
Feb 10Calculating The Intrinsic Value Of Granules India Limited (NSE:GRANULES)
Feb 02Here's Why We Think Granules India (NSE:GRANULES) Is Well Worth Watching
Jan 20These 4 Measures Indicate That Granules India (NSE:GRANULES) Is Using Debt Reasonably Well
Dec 21Here's Why I Think Granules India (NSE:GRANULES) Is An Interesting Stock
Aug 18Granules India (NSE:GRANULES) Will Pay A Dividend Of ₹0.25
Aug 03Is Granules India (NSE:GRANULES) Using Too Much Debt?
Jun 11Why Granules India Limited (NSE:GRANULES) Is A Dividend Rockstar
May 02Does This Valuation Of Granules India Limited (NSE:GRANULES) Imply Investors Are Overpaying?
Mar 26What Kind Of Investors Own Most Of Granules India Limited (NSE:GRANULES)?
Mar 14These 4 Measures Indicate That Granules India (NSE:GRANULES) Is Using Debt Reasonably Well
Mar 01Granules India Limited (NSE:GRANULES) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Feb 16Why You Might Be Interested In Granules India Limited (NSE:GRANULES) For Its Upcoming Dividend
Feb 03Analysts Have Made A Financial Statement On Granules India Limited's (NSE:GRANULES) Third-Quarter Report
Jan 30Here's Why We Think Granules India (NSE:GRANULES) Is Well Worth Watching
Jan 20
収支内訳
収支内訳
Granules India の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 31 Mar 24 | 45,064 | 4,053 | 5,979 | 0 |
| 31 Dec 23 | 45,261 | 3,953 | 5,877 | 0 |
| 30 Sep 23 | 45,166 | 3,939 | 5,499 | 0 |
| 30 Jun 23 | 44,779 | 4,369 | 5,187 | 0 |
| 31 Mar 23 | 45,119 | 5,166 | 4,872 | 0 |
| 31 Dec 22 | 43,464 | 5,080 | 4,781 | 0 |
| 30 Sep 22 | 41,970 | 4,845 | 4,643 | 0 |
| 30 Jun 22 | 39,346 | 4,201 | 4,391 | 0 |
| 31 Mar 22 | 37,649 | 4,128 | 4,123 | 0 |
| 31 Dec 21 | 35,343 | 4,293 | 4,113 | 0 |
| 30 Sep 21 | 33,820 | 4,753 | 4,069 | 0 |
| 30 Jun 21 | 33,518 | 5,582 | 4,189 | 0 |
| 31 Mar 21 | 32,375 | 5,495 | 4,248 | 0 |
| 31 Dec 20 | 30,381 | 5,142 | 3,412 | 0 |
| 30 Sep 20 | 28,976 | 4,314 | 3,228 | 0 |
| 30 Jun 20 | 27,390 | 3,636 | 2,857 | 0 |
| 31 Mar 20 | 25,986 | 3,354 | 3,217 | 0 |
| 31 Dec 19 | 26,121 | 3,071 | 2,537 | 0 |
| 30 Sep 19 | 25,399 | 3,034 | 2,425 | 0 |
| 30 Jun 19 | 24,212 | 2,679 | 2,166 | 0 |
| 31 Mar 19 | 22,792 | 2,364 | 2,269 | 0 |
| 31 Dec 18 | 21,697 | 1,928 | 2,158 | 0 |
| 30 Sep 18 | 19,487 | 1,675 | 2,037 | 0 |
| 30 Jun 18 | 17,603 | 1,476 | 1,764 | 0 |
| 31 Mar 18 | 16,846 | 1,326 | 1,801 | 0 |
| 31 Dec 17 | 15,361 | 1,578 | 1,692 | 0 |
| 30 Sep 17 | 14,785 | 1,619 | 1,638 | 0 |
| 30 Jun 17 | 14,456 | 1,624 | 1,453 | 0 |
| 31 Mar 17 | 14,106 | 1,645 | 1,504 | 0 |
| 31 Dec 16 | 14,971 | 1,473 | 1,614 | 85 |
| 30 Sep 16 | 14,626 | 1,374 | 1,479 | 63 |
| 30 Jun 16 | 14,524 | 1,289 | 1,423 | 28 |
| 31 Mar 16 | 13,572 | 1,230 | 1,283 | 0 |
| 31 Dec 15 | 14,147 | 1,077 | 2,377 | 187 |
| 30 Sep 15 | 13,895 | 1,041 | 2,366 | 160 |
| 30 Jun 15 | 13,307 | 952 | 2,317 | 134 |
| 31 Mar 15 | 12,937 | 909 | 1,155 | 0 |
| 31 Dec 14 | 12,573 | 921 | 2,261 | 51 |
| 30 Sep 14 | 12,217 | 904 | 2,188 | 57 |
| 30 Jun 14 | 11,786 | 834 | 1,472 | 64 |
| 31 Mar 14 | 10,973 | 752 | 2,051 | 94 |
| 31 Dec 13 | 9,837 | 640 | 1,656 | 49 |
| 30 Sep 13 | 8,948 | 480 | 1,569 | 51 |
質の高い収益: GRANULESは 高品質の収益 を持っています。
利益率の向上: GRANULESの現在の純利益率 (9%)は、昨年(11.4%)よりも低くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: GRANULESの収益は過去 5 年間で年間7.2%増加しました。
成長の加速: GRANULESは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。
収益対業界: GRANULESは過去 1 年間で収益成長率がマイナス ( -21.5% ) となったため、 Pharmaceuticals業界平均 ( 18% ) と比較することが困難です。
株主資本利益率
高いROE: GRANULESの 自己資本利益率 ( 12.6% ) は 低い とみなされます。